- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Synageva BioPharma Corp+ Add to Watchlist
GEVA:US218.1100 USD 2.3200 1.08%
As of 20:10:00 ET on 05/22/2015.
Company Profile for Synageva BioPharma Corp (GEVA)
Synageva BioPharma Corp. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.
Synageva BioPharma Corp
Key Executives for Synageva BioPharma Corp (GEVA)
|Sanj K PatelPresident/CEO||Robert Bazemore "Rob"Chief Operating Officer|
|Anthony G QuinnExec VP/Chief Medical Officer||Carsten BoessSenior VP/CFO|
|Glen WilliamsSenior VP:Global Technical Ops||Matthew S OsborneVP:Investor Relations|